ProfileGDS4718 / 210802_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 44% 62% 45% 43% 76% 79% 46% 42% 49% 51% 45% 66% 71% 71% 61% 55% 63% 71% 43% 38% 43% 47% 54% 49% 72% 49% 58% 34% 72% 72% 70% 33% 43% 73% 78% 61% 42% 40% 67% 48% 65% 63% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4895850
GSM549102patient 115, normal, homogenized [OPG study]5.1946944
GSM549104patient 119, normal, homogenized [OPG study]6.3231662
GSM549108patient 138, normal, homogenized [OPG study]5.2748945
GSM549119patient 077, normal, homogenized [OPG study]5.1447743
GSM549133patient 032, cancer, homogenized [OPG study]7.5456976
GSM549139patient 042, cancer, homogenized [OPG study]7.768579
GSM549099patient 107, normal, homogenized [OPG study]5.3125346
GSM549109patient 139, normal, homogenized [OPG study]5.128742
GSM549110patient 046, normal, homogenized [OPG study]5.4468249
GSM549114patient 063, normal, homogenized [OPG study]5.5145151
GSM549122patient 082, normal, homogenized [OPG study]5.2490145
GSM549134patient 033, cancer, homogenized [OPG study]6.5105766
GSM549136patient 036, cancer, homogenized [OPG study]7.0301171
GSM549140patient 044, cancer, homogenized [OPG study]7.0208471
GSM549111patient 047, normal, homogenized [OPG study]6.1848161
GSM549113patient 057, normal, homogenized [OPG study]5.7883755
GSM549132patient 031, cancer, homogenized [OPG study]6.3272763
GSM549137patient 038, cancer, homogenized [OPG study]7.0083671
GSM549142patient 047, cancer, homogenized [OPG study]5.2909443
GSM549100patient 110, normal, homogenized [OPG study]4.9040838
GSM549107patient 135, normal, homogenized [OPG study]5.1194143
GSM549115patient 068, normal, homogenized [OPG study]5.2688347
GSM549116patient 072, normal, homogenized [OPG study]5.7307254
GSM549120patient 078, normal, homogenized [OPG study]5.4475349
GSM549131patient 030, cancer, homogenized [OPG study]7.0939272
GSM549118patient 074, normal, homogenized [OPG study]5.4528949
GSM549129patient 027, cancer, homogenized [OPG study]5.9905158
GSM549123patient 088, normal, homogenized [OPG study]4.7149634
GSM549124patient 006, cancer, homogenized [OPG study]7.0141372
GSM549126patient 015, cancer, homogenized [OPG study]7.0737172
GSM549128patient 025, cancer, homogenized [OPG study]6.9268370
GSM549103patient 117, normal, homogenized [OPG study]4.7100533
GSM549117patient 073, normal, homogenized [OPG study]5.0818943
GSM549138patient 041, cancer, homogenized [OPG study]7.2071173
GSM549141patient 045, cancer, homogenized [OPG study]7.739478
GSM549130patient 028, cancer, homogenized [OPG study]6.1777261
GSM549101patient 111, normal, homogenized [OPG study]5.1067342
GSM549105patient 128, normal, homogenized [OPG study]4.9965540
GSM549106patient 134, normal, homogenized [OPG study]6.6362267
GSM549112patient 048, normal, homogenized [OPG study]5.421148
GSM549125patient 011, cancer, homogenized [OPG study]6.5056165
GSM549127patient 024, cancer, homogenized [OPG study]6.4172563
GSM549135patient 035, cancer, homogenized [OPG study]7.0675771